Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker KALA
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Oct 23, 2025 | Mary Reumuth CHIEF FINANCIAL OFFICER | KALA KALA BIO, Inc. | Sale | 967 | $0.82 | $793 Sale | Form 4 ↗ |
| Oct 23, 2025 | Mark T. Iwicki Director | KALA KALA BIO, Inc. | Sale | 154,894 | $0.81 | $125.5K Sale | Form 4 ↗ |
| Oct 22, 2025 | Darius Kharabi CHIEF BUSINESS OFFICER | KALA KALA BIO, Inc. | Sale | 20,806 | $0.83 | $17.3K Sale | Form 4 ↗ |
| Oct 22, 2025 | Mary Reumuth CHIEF FINANCIAL OFFICER | KALA KALA BIO, Inc. | Sale | 32,230 | $0.83 | $26.8K Sale | Form 4 ↗ |
| Oct 22, 2025 | Todd Bazemore Director | KALA KALA BIO, Inc. | Sale | 47,768 | $0.83 | $39.6K Sale | Form 4 ↗ |
| Oct 22, 2025 | Romulus K. Brazzell SEE REMARKS | KALA KALA BIO, Inc. | Sale | 46,748 | $0.83 | $38.8K Sale | Form 4 ↗ |
| Oct 1, 2025 | Julian Baker | KALA KALA BIO, Inc. | Sale | 462,967 | $1.38 | $638.9K Sale | Form 4 ↗ |
| Oct 1, 2025 | Julian Baker | KALA KALA BIO, Inc. | Sale | 50,640 | $1.38 | $69.9K Sale | Form 4 ↗ |
| Sep 30, 2025 | Julian Baker | KALA KALA BIO, Inc. | Sale | 195,425 | $1.60 | $312.7K Sale | Form 4 ↗ |
| Sep 30, 2025 | Julian Baker | KALA KALA BIO, Inc. | Sale | 21,376 | $1.60 | $34.2K Sale | Form 4 ↗ |
| Jun 24, 2025 | Darius Kharabi CHIEF BUSINESS OFFICER | KALA KALA BIO, Inc. | Sale | 4,511 | $4.01 | $18.1K Sale | Form 4 ↗ |
| Jun 24, 2025 | Mary Reumuth CHIEF FINANCIAL OFFICER | KALA KALA BIO, Inc. | Sale | 3,631 | $4.01 | $14.6K Sale | Form 4 ↗ |
| Jun 24, 2025 | Todd Bazemore SEE REMARKS | KALA KALA BIO, Inc. | Sale | 4,058 | $4.01 | $16.3K Sale | Form 4 ↗ |
| Jun 24, 2025 | Romulus K. Brazzell SEE REMARKS | KALA KALA BIO, Inc. | Sale | 5,251 | $4.01 | $21.1K Sale | Form 4 ↗ |
| Jun 24, 2025 | Mark T. Iwicki Director | KALA KALA BIO, Inc. | Sale | 13,227 | $4.01 | $53.0K Sale | Form 4 ↗ |
| Jun 3, 2025 | Darius Kharabi CHIEF BUSINESS OFFICER | KALA KALA BIO, Inc. | Sale | 730 | $3.74 | $2,730 Sale | Form 4 ↗ |
| Jun 3, 2025 | Mary Reumuth CHIEF FINANCIAL OFFICER | KALA KALA BIO, Inc. | Sale | 2,850 | $3.74 | $10.7K Sale | Form 4 ↗ |
| Jun 3, 2025 | Todd Bazemore SEE REMARKS | KALA KALA BIO, Inc. | Sale | 3,390 | $3.74 | $12.7K Sale | Form 4 ↗ |
| Jun 3, 2025 | Romulus K. Brazzell SEE REMARKS | KALA KALA BIO, Inc. | Sale | 3,687 | $3.74 | $13.8K Sale | Form 4 ↗ |
| Jun 3, 2025 | Mark T. Iwicki Director | KALA KALA BIO, Inc. | Sale | 10,866 | $3.74 | $40.6K Sale | Form 4/A ↗ |
| Jan 6, 2025 | Darius Kharabi CHIEF BUSINESS OFFICER | KALA KALA BIO, Inc. | Sale | 2,021 | $7.63 | $15.4K Sale | Form 4 ↗ |
| Jan 6, 2025 | Todd Bazemore SEE REMARKS | KALA KALA BIO, Inc. | Sale | 1,993 | $7.63 | $15.2K Sale | Form 4 ↗ |
| Jan 6, 2025 | Mark T. Iwicki CHIEF EXECUTIVE OFFICER, Director | KALA KALA BIO, Inc. | Sale | 5,779 | $7.63 | $44.1K Sale | Form 4 ↗ |
| Jan 6, 2025 | Mary Reumuth CHIEF FINANCIAL OFFICER | KALA KALA BIO, Inc. | Sale | 1,706 | $7.63 | $13.0K Sale | Form 4 ↗ |
| Dec 30, 2024 | Felix Baker 10% owner | KALA KALA BIO, Inc. | Buy | 279,939 | $6.44 | $1.8M Buy | Form 4 ↗ |
| Dec 30, 2024 | Felix Baker 10% owner | KALA KALA BIO, Inc. | Buy | 30,620 | $6.44 | $197.2K Buy | Form 4 ↗ |
26 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 6:31 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances